Because 5-amino-1MQ is not a compounding-pharmacy-accessible substance and is not an FDA-approved therapy, the safety discussion is primarily about what physicians should tell patients asking about it, rather than about clinical monitoring parameters for active therapy
in vivo, it did not deliver the obesity outcomes anticipated
No tiered minimums, no fine print five vials normally cost 138,000 but drop to 103,500 with the bulk discount applied
Food and Drug Administration (FDA) for medical use in humans
As the OPPS acquires claims data regarding hospital costs associated with new procedures, we regularly examine the claims data and any available new information regarding the clinical aspects of new procedures to confirm that our OPPS payments remain appropriate for procedures as they transition into mainstream medical practice (77 FR 68314)
We base each of our health plans on the unique needs of your body